Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Intravenous-to-Subcutaneous Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Amgen
5.1.1 Amgen Company Profile
5.1.2 Amgen Business Overview
5.1.3 Amgen Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Amgen Intravenous-to-Subcutaneous Drugs Products Introduction
5.2 Grifols
5.2.1 Grifols Company Profile
5.2.2 Grifols Business Overview
5.2.3 Grifols Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Grifols Intravenous-to-Subcutaneous Drugs Products Introduction
5.3 US Worldmeds
5.3.1 US Worldmeds Company Profile
5.3.2 US Worldmeds Business Overview
5.3.3 US Worldmeds Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 US Worldmeds Intravenous-to-Subcutaneous Drugs Products Introduction
5.4 United Therapeutics
5.4.1 United Therapeutics Company Profile
5.4.2 United Therapeutics Business Overview
5.4.3 United Therapeutics Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 United Therapeutics Intravenous-to-Subcutaneous Drugs Products Introduction
5.5 Octapharma
5.5.1 Octapharma Company Profile
5.5.2 Octapharma Business Overview
5.5.3 Octapharma Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Octapharma Intravenous-to-Subcutaneous Drugs Products Introduction
5.6 ScPharmceuticals
5.6.1 ScPharmceuticals Company Profile
5.6.2 ScPharmceuticals Business Overview
5.6.3 ScPharmceuticals Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 ScPharmceuticals Intravenous-to-Subcutaneous Drugs Products Introduction
5.7 Rhythm Metabolic
5.7.1 Rhythm Metabolic Company Profile
5.7.2 Rhythm Metabolic Business Overview
5.7.3 Rhythm Metabolic Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Rhythm Metabolic Intravenous-to-Subcutaneous Drugs Products Introduction
5.8 Janssen
5.8.1 Janssen Company Profile
5.8.2 Janssen Business Overview
5.8.3 Janssen Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Janssen Intravenous-to-Subcutaneous Drugs Products Introduction
5.9 Britannia
5.9.1 Britannia Company Profile
5.9.2 Britannia Business Overview
5.9.3 Britannia Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Britannia Intravenous-to-Subcutaneous Drugs Products Introduction
5.10 Takeda
5.10.1 Takeda Company Profile
5.10.2 Takeda Business Overview
5.10.3 Takeda Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Takeda Intravenous-to-Subcutaneous Drugs Products Introduction
5.11 NeuroDerm
5.11.1 NeuroDerm Company Profile
5.11.2 NeuroDerm Business Overview
5.11.3 NeuroDerm Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 NeuroDerm Intravenous-to-Subcutaneous Drugs Products Introduction
5.12 GlaxoSmithKline
5.12.1 GlaxoSmithKline Company Profile
5.12.2 GlaxoSmithKline Business Overview
5.12.3 GlaxoSmithKline Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 GlaxoSmithKline Intravenous-to-Subcutaneous Drugs Products Introduction
5.13 UCB
5.13.1 UCB Company Profile
5.13.2 UCB Business Overview
5.13.3 UCB Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 UCB Intravenous-to-Subcutaneous Drugs Products Introduction
5.14 Ferring
5.14.1 Ferring Company Profile
5.14.2 Ferring Business Overview
5.14.3 Ferring Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Ferring Intravenous-to-Subcutaneous Drugs Products Introduction
5.15 CSL Behring
5.15.1 CSL Behring Company Profile
5.15.2 CSL Behring Business Overview
5.15.3 CSL Behring Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 CSL Behring Intravenous-to-Subcutaneous Drugs Products Introduction
5.16 Roche
5.16.1 Roche Company Profile
5.16.2 Roche Business Overview
5.16.3 Roche Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Roche Intravenous-to-Subcutaneous Drugs Products Introduction
5.17 Capricor
5.17.1 Capricor Company Profile
5.17.2 Capricor Business Overview
5.17.3 Capricor Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Capricor Intravenous-to-Subcutaneous Drugs Products Introduction
5.18 AstraZeneca
5.18.1 AstraZeneca Company Profile
5.18.2 AstraZeneca Business Overview
5.18.3 AstraZeneca Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 AstraZeneca Intravenous-to-Subcutaneous Drugs Products Introduction
5.19 Baxter
5.19.1 Baxter Company Profile
5.19.2 Baxter Business Overview
5.19.3 Baxter Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Baxter Intravenous-to-Subcutaneous Drugs Products Introduction
5.20 SteadyMed
5.20.1 SteadyMed Company Profile
5.20.2 SteadyMed Business Overview
5.20.3 SteadyMed Intravenous-to-Subcutaneous Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 SteadyMed Intravenous-to-Subcutaneous Drugs Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Intravenous-to-Subcutaneous Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Intravenous-to-Subcutaneous Drugs Price by Types (2015-2020)
6.2 Global Intravenous-to-Subcutaneous Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Intravenous-to-Subcutaneous Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Intravenous-to-Subcutaneous Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Antibiotics
6.3.2 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Antibodies
6.3.3 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Anticoagulants
6.3.4 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Antiemetics
6.3.5 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Blood Factors
6.3.6 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Diuretics
6.3.7 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Hormones
6.3.8 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Plasma-derived Immune Inhibitors
6.3.9 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Recombinant Immunotherapeutics
6.3.10 Global Intravenous-to-Subcutaneous Drugs Sales, Price and Growth Rate of Vasodilators
6.4 Global Intravenous-to-Subcutaneous Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Antibiotics Market Revenue and Sales Forecast (2020-2025)
6.4.2 Antibodies Market Revenue and Sales Forecast (2020-2025)
6.4.3 Anticoagulants Market Revenue and Sales Forecast (2020-2025)
6.4.4 Antiemetics Market Revenue and Sales Forecast (2020-2025)
6.4.5 Blood Factors Market Revenue and Sales Forecast (2020-2025)
6.4.6 Diuretics Market Revenue and Sales Forecast (2020-2025)
6.4.7 Hormones Market Revenue and Sales Forecast (2020-2025)
6.4.8 Plasma-derived Immune Inhibitors Market Revenue and Sales Forecast (2020-2025)
6.4.9 Recombinant Immunotherapeutics Market Revenue and Sales Forecast (2020-2025)
6.4.10 Vasodilators Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Intravenous-to-Subcutaneous Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Intravenous-to-Subcutaneous Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Intravenous-to-Subcutaneous Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Intravenous-to-Subcutaneous Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Intravenous-to-Subcutaneous Drugs Revenue, Sales and Growth Rate of Medical Care (2015-2020)
7.3.2 Global Intravenous-to-Subcutaneous Drugs Revenue, Sales and Growth Rate of Hospital (2015-2020)
7.4 Global Intravenous-to-Subcutaneous Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Medical Care Market Revenue and Sales Forecast (2020-2025)
7.4.2 Hospital Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Intravenous-to-Subcutaneous Drugs Sales by Regions (2015-2020)
8.2 Global Intravenous-to-Subcutaneous Drugs Market Revenue by Regions (2015-2020)
8.3 Global Intravenous-to-Subcutaneous Drugs Market Forecast by Regions (2020-2025)

9 North America Intravenous-to-Subcutaneous Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Intravenous-to-Subcutaneous Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Intravenous-to-Subcutaneous Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Intravenous-to-Subcutaneous Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Intravenous-to-Subcutaneous Drugs Market Analysis by Country
9.6.1 U.S. Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
9.6.2 Canada Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
9.6.3 Mexico Intravenous-to-Subcutaneous Drugs Sales and Growth Rate

10 Europe Intravenous-to-Subcutaneous Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Intravenous-to-Subcutaneous Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Intravenous-to-Subcutaneous Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Intravenous-to-Subcutaneous Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Intravenous-to-Subcutaneous Drugs Market Analysis by Country
10.6.1 Germany Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
10.6.2 United Kingdom Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
10.6.3 France Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
10.6.4 Italy Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
10.6.5 Spain Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
10.6.6 Russia Intravenous-to-Subcutaneous Drugs Sales and Growth Rate

11 Asia-Pacific Intravenous-to-Subcutaneous Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Intravenous-to-Subcutaneous Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Intravenous-to-Subcutaneous Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Intravenous-to-Subcutaneous Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Intravenous-to-Subcutaneous Drugs Market Analysis by Country
11.6.1 China Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
11.6.2 Japan Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
11.6.3 South Korea Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
11.6.4 Australia Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
11.6.5 India Intravenous-to-Subcutaneous Drugs Sales and Growth Rate

12 South America Intravenous-to-Subcutaneous Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Intravenous-to-Subcutaneous Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Intravenous-to-Subcutaneous Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Intravenous-to-Subcutaneous Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Intravenous-to-Subcutaneous Drugs Market Analysis by Country
12.6.1 Brazil Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
12.6.2 Argentina Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
12.6.3 Columbia Intravenous-to-Subcutaneous Drugs Sales and Growth Rate

13 Middle East and Africa Intravenous-to-Subcutaneous Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Intravenous-to-Subcutaneous Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Intravenous-to-Subcutaneous Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Intravenous-to-Subcutaneous Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Intravenous-to-Subcutaneous Drugs Market Analysis by Country
13.6.1 UAE Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
13.6.2 Egypt Intravenous-to-Subcutaneous Drugs Sales and Growth Rate
13.6.3 South Africa Intravenous-to-Subcutaneous Drugs Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source